SCHEMBL29566254

SCHEMBL29566254

Cc1cccc(C)c1-c1cc(Oc2cc(Cl)c(Br)c(Cl)c2)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PTPN11 Q06124 1/20 0.35
▸ CCNT1 O60563 1/20 0.34
▸ CCNB2 O95067 1/20 0.34
▸ CCNE2 O96020 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ CCNB3 Q8WWL7 1/20 0.34
▸ HTR1A P08908 2/20 0.34
▸ HTR7 P34969 2/20 0.34
▸ BRD4 O60885 2/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ MTOR P42345 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566775 0.97 TSHR (0.34) TSHRSMN1; SMN2PTPN11CCNT1CCNB2
SCHEMBL24309674 0.92 TSHR (0.37) TSHRSMN1; SMN2HTR1AHTR7BRD4
SCHEMBL29566748 0.88 GAA (0.40) TSHRSMN1; SMN2HTR1AHTR7BRD4
SCHEMBL24310086 0.88 GAA (0.40) TSHRSMN1; SMN2HTR1AHTR7BRD4
SCHEMBL26810218 0.88 KMT2A (0.40) TSHRSMN1; SMN2KDREGFRFGFR1
SCHEMBL26808238 0.88 DGAT2 (0.36) TSHRSMN1; SMN2PTPN11CCNT1CCNB2
SCHEMBL29566612 0.87 TSHR (0.43) TSHRSMN1; SMN2HTR1AHTR7BRD4
SCHEMBL24310345 0.87 TSHR (0.43) TSHRSMN1; SMN2HTR1AHTR7BRD4
SCHEMBL24310121 0.86 BRD4 (0.39) TSHRSMN1; SMN2PTPN11CCNT1CCNB2
SCHEMBL24310534 0.86 DGAT2 (0.35) TSHRSMN1; SMN2PTPN11CCNT1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback